[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global Memory Impairment Treatment Market Size, Status and Forecast 2020-2026

September 2020 | 92 pages | ID: C3EC4803C370EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
This report focuses on the global Memory Impairment Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Memory Impairment Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
  • F. Hoffmann-La Roche Ltd.
  • Suven Life Sciences Ltd.
  • Met P Pharma AG
  • Dart NeuroScience LLC.
  • Omeros Corporation
  • Sunovion Pharmaceuticals Inc.
  • AbbVie Inc.
Market segment by Type, the product can be split into
  • HT-3951
  • 2-PMPA
  • Meldonium
  • AC-253
  • RO-4938581
  • Others
Market segment by Application, split into
  • Clinic
  • Hospital
  • Others
Market segment by Regions/Countries, this report covers
  • North America
  • Europe
  • China
  • Japan
  • Southeast Asia
  • India
  • Central & South America
The study objectives of this report are:
  • To analyze global Memory Impairment Treatment status, future forecast, growth opportunity, key market and key players.
  • To present the Memory Impairment Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
  • To strategically profile the key players and comprehensively analyze their development plan and strategies.
  • To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Memory Impairment Treatment are as follows:
  • History Year: 2015-2019
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Memory Impairment Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Memory Impairment Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 HT-3951
  1.4.3 2-PMPA
  1.4.4 Meldonium
  1.4.5 AC-253
  1.4.6 RO-4938581
  1.4.7 Others
1.5 Market by Application
  1.5.1 Global Memory Impairment Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Clinic
  1.5.3 Hospital
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Memory Impairment Treatment Industry Impact
  1.6.1 How the Covid-19 is Affecting the Memory Impairment Treatment Industry
    1.6.1.1 Memory Impairment Treatment Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Memory Impairment Treatment Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Memory Impairment Treatment Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Memory Impairment Treatment Market Perspective (2015-2026)
2.2 Memory Impairment Treatment Growth Trends by Regions
  2.2.1 Memory Impairment Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Memory Impairment Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Memory Impairment Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Memory Impairment Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Memory Impairment Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Memory Impairment Treatment Players by Market Size
  3.1.1 Global Top Memory Impairment Treatment Players by Revenue (2015-2020)
  3.1.2 Global Memory Impairment Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Memory Impairment Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Memory Impairment Treatment Market Concentration Ratio
  3.2.1 Global Memory Impairment Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Memory Impairment Treatment Revenue in 2019
3.3 Memory Impairment Treatment Key Players Head office and Area Served
3.4 Key Players Memory Impairment Treatment Product Solution and Service
3.5 Date of Enter into Memory Impairment Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Memory Impairment Treatment Historic Market Size by Type (2015-2020)
4.2 Global Memory Impairment Treatment Forecasted Market Size by Type (2021-2026)

5 MEMORY IMPAIRMENT TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Memory Impairment Treatment Market Size by Application (2015-2020)
5.2 Global Memory Impairment Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Memory Impairment Treatment Market Size (2015-2020)
6.2 Memory Impairment Treatment Key Players in North America (2019-2020)
6.3 North America Memory Impairment Treatment Market Size by Type (2015-2020)
6.4 North America Memory Impairment Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Memory Impairment Treatment Market Size (2015-2020)
7.2 Memory Impairment Treatment Key Players in Europe (2019-2020)
7.3 Europe Memory Impairment Treatment Market Size by Type (2015-2020)
7.4 Europe Memory Impairment Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Memory Impairment Treatment Market Size (2015-2020)
8.2 Memory Impairment Treatment Key Players in China (2019-2020)
8.3 China Memory Impairment Treatment Market Size by Type (2015-2020)
8.4 China Memory Impairment Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Memory Impairment Treatment Market Size (2015-2020)
9.2 Memory Impairment Treatment Key Players in Japan (2019-2020)
9.3 Japan Memory Impairment Treatment Market Size by Type (2015-2020)
9.4 Japan Memory Impairment Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Memory Impairment Treatment Market Size (2015-2020)
10.2 Memory Impairment Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Memory Impairment Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Memory Impairment Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Memory Impairment Treatment Market Size (2015-2020)
11.2 Memory Impairment Treatment Key Players in India (2019-2020)
11.3 India Memory Impairment Treatment Market Size by Type (2015-2020)
11.4 India Memory Impairment Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Memory Impairment Treatment Market Size (2015-2020)
12.2 Memory Impairment Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Memory Impairment Treatment Market Size by Type (2015-2020)
12.4 Central & South America Memory Impairment Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 F. Hoffmann-La Roche Ltd.
  13.1.1 F. Hoffmann-La Roche Ltd. Company Details
  13.1.2 F. Hoffmann-La Roche Ltd. Business Overview and Its Total Revenue
  13.1.3 F. Hoffmann-La Roche Ltd. Memory Impairment Treatment Introduction
  13.1.4 F. Hoffmann-La Roche Ltd. Revenue in Memory Impairment Treatment Business (2015-2020))
  13.1.5 F. Hoffmann-La Roche Ltd. Recent Development
13.2 Suven Life Sciences Ltd.
  13.2.1 Suven Life Sciences Ltd. Company Details
  13.2.2 Suven Life Sciences Ltd. Business Overview and Its Total Revenue
  13.2.3 Suven Life Sciences Ltd. Memory Impairment Treatment Introduction
  13.2.4 Suven Life Sciences Ltd. Revenue in Memory Impairment Treatment Business (2015-2020)
  13.2.5 Suven Life Sciences Ltd. Recent Development
13.3 Met P Pharma AG
  13.3.1 Met P Pharma AG Company Details
  13.3.2 Met P Pharma AG Business Overview and Its Total Revenue
  13.3.3 Met P Pharma AG Memory Impairment Treatment Introduction
  13.3.4 Met P Pharma AG Revenue in Memory Impairment Treatment Business (2015-2020)
  13.3.5 Met P Pharma AG Recent Development
13.4 Dart NeuroScience LLC.
  13.4.1 Dart NeuroScience LLC. Company Details
  13.4.2 Dart NeuroScience LLC. Business Overview and Its Total Revenue
  13.4.3 Dart NeuroScience LLC. Memory Impairment Treatment Introduction
  13.4.4 Dart NeuroScience LLC. Revenue in Memory Impairment Treatment Business (2015-2020)
  13.4.5 Dart NeuroScience LLC. Recent Development
13.5 Omeros Corporation
  13.5.1 Omeros Corporation Company Details
  13.5.2 Omeros Corporation Business Overview and Its Total Revenue
  13.5.3 Omeros Corporation Memory Impairment Treatment Introduction
  13.5.4 Omeros Corporation Revenue in Memory Impairment Treatment Business (2015-2020)
  13.5.5 Omeros Corporation Recent Development
13.6 Sunovion Pharmaceuticals Inc.
  13.6.1 Sunovion Pharmaceuticals Inc. Company Details
  13.6.2 Sunovion Pharmaceuticals Inc. Business Overview and Its Total Revenue
  13.6.3 Sunovion Pharmaceuticals Inc. Memory Impairment Treatment Introduction
  13.6.4 Sunovion Pharmaceuticals Inc. Revenue in Memory Impairment Treatment Business (2015-2020)
  13.6.5 Sunovion Pharmaceuticals Inc. Recent Development
13.7 AbbVie Inc.
  13.7.1 AbbVie Inc. Company Details
  13.7.2 AbbVie Inc. Business Overview and Its Total Revenue
  13.7.3 AbbVie Inc. Memory Impairment Treatment Introduction
  13.7.4 AbbVie Inc. Revenue in Memory Impairment Treatment Business (2015-2020)
  13.7.5 AbbVie Inc. Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES

Table 1. Memory Impairment Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Memory Impairment Treatment Revenue
Table 3. Ranking of Global Top Memory Impairment Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Memory Impairment Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of HT-3951
Table 6. Key Players of 2-PMPA
Table 7. Key Players of Meldonium
Table 8. Key Players of AC-253
Table 9. Key Players of RO-4938581
Table 10. Key Players of Others
Table 11. COVID-19 Impact Global Market: (Four Memory Impairment Treatment Market Size Forecast Scenarios)
Table 12. Opportunities and Trends for Memory Impairment Treatment Players in the COVID-19 Landscape
Table 13. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 14. Key Regions/Countries Measures against Covid-19 Impact
Table 15. Proposal for Memory Impairment Treatment Players to Combat Covid-19 Impact
Table 16. Global Memory Impairment Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 17. Global Memory Impairment Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 18. Global Memory Impairment Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 19. Global Memory Impairment Treatment Market Share by Regions (2015-2020)
Table 20. Global Memory Impairment Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 21. Global Memory Impairment Treatment Market Share by Regions (2021-2026)
Table 22. Market Top Trends
Table 23. Key Drivers: Impact Analysis
Table 24. Key Challenges
Table 25. Memory Impairment Treatment Market Growth Strategy
Table 26. Main Points Interviewed from Key Memory Impairment Treatment Players
Table 27. Global Memory Impairment Treatment Revenue by Players (2015-2020) (Million US$)
Table 28. Global Memory Impairment Treatment Market Share by Players (2015-2020)
Table 29. Global Top Memory Impairment Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Impairment Treatment as of 2019)
Table 30. Global Memory Impairment Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 31. Key Players Headquarters and Area Served
Table 32. Key Players Memory Impairment Treatment Product Solution and Service
Table 33. Date of Enter into Memory Impairment Treatment Market
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. Global Memory Impairment Treatment Market Size Share by Type (2015-2020)
Table 37. Global Memory Impairment Treatment Revenue Market Share by Type (2021-2026)
Table 38. Global Memory Impairment Treatment Market Size Share by Application (2015-2020)
Table 39. Global Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 40. Global Memory Impairment Treatment Market Size Share by Application (2021-2026)
Table 41. North America Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 42. North America Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 43. North America Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 44. North America Memory Impairment Treatment Market Share by Type (2015-2020)
Table 45. North America Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 46. North America Memory Impairment Treatment Market Share by Application (2015-2020)
Table 47. Europe Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 48. Europe Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 49. Europe Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 50. Europe Memory Impairment Treatment Market Share by Type (2015-2020)
Table 51. Europe Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 52. Europe Memory Impairment Treatment Market Share by Application (2015-2020)
Table 53. China Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 54. China Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 55. China Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 56. China Memory Impairment Treatment Market Share by Type (2015-2020)
Table 57. China Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 58. China Memory Impairment Treatment Market Share by Application (2015-2020)
Table 59. Japan Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 60. Japan Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 61. Japan Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 62. Japan Memory Impairment Treatment Market Share by Type (2015-2020)
Table 63. Japan Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 64. Japan Memory Impairment Treatment Market Share by Application (2015-2020)
Table 65. Southeast Asia Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 66. Southeast Asia Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 67. Southeast Asia Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 68. Southeast Asia Memory Impairment Treatment Market Share by Type (2015-2020)
Table 69. Southeast Asia Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 70. Southeast Asia Memory Impairment Treatment Market Share by Application (2015-2020)
Table 71. India Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 72. India Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 73. India Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 74. India Memory Impairment Treatment Market Share by Type (2015-2020)
Table 75. India Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 76. India Memory Impairment Treatment Market Share by Application (2015-2020)
Table 77. Central & South America Key Players Memory Impairment Treatment Revenue (2019-2020) (Million US$)
Table 78. Central & South America Key Players Memory Impairment Treatment Market Share (2019-2020)
Table 79. Central & South America Memory Impairment Treatment Market Size by Type (2015-2020) (Million US$)
Table 80. Central & South America Memory Impairment Treatment Market Share by Type (2015-2020)
Table 81. Central & South America Memory Impairment Treatment Market Size by Application (2015-2020) (Million US$)
Table 82. Central & South America Memory Impairment Treatment Market Share by Application (2015-2020)
Table 83. F. Hoffmann-La Roche Ltd. Company Details
Table 84. F. Hoffmann-La Roche Ltd. Business Overview
Table 85. F. Hoffmann-La Roche Ltd. Product
Table 86. F. Hoffmann-La Roche Ltd. Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 87. F. Hoffmann-La Roche Ltd. Recent Development
Table 88. Suven Life Sciences Ltd. Company Details
Table 89. Suven Life Sciences Ltd. Business Overview
Table 90. Suven Life Sciences Ltd. Product
Table 91. Suven Life Sciences Ltd. Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 92. Suven Life Sciences Ltd. Recent Development
Table 93. Met P Pharma AG Company Details
Table 94. Met P Pharma AG Business Overview
Table 95. Met P Pharma AG Product
Table 96. Met P Pharma AG Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 97. Met P Pharma AG Recent Development
Table 98. Dart NeuroScience LLC. Company Details
Table 99. Dart NeuroScience LLC. Business Overview
Table 100. Dart NeuroScience LLC. Product
Table 101. Dart NeuroScience LLC. Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 102. Dart NeuroScience LLC. Recent Development
Table 103. Omeros Corporation Company Details
Table 104. Omeros Corporation Business Overview
Table 105. Omeros Corporation Product
Table 106. Omeros Corporation Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 107. Omeros Corporation Recent Development
Table 108. Sunovion Pharmaceuticals Inc. Company Details
Table 109. Sunovion Pharmaceuticals Inc. Business Overview
Table 110. Sunovion Pharmaceuticals Inc. Product
Table 111. Sunovion Pharmaceuticals Inc. Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 112. Sunovion Pharmaceuticals Inc. Recent Development
Table 113. AbbVie Inc. Company Details
Table 114. AbbVie Inc. Business Overview
Table 115. AbbVie Inc. Product
Table 116. AbbVie Inc. Revenue in Memory Impairment Treatment Business (2015-2020) (Million US$)
Table 117. AbbVie Inc. Recent Development
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global Memory Impairment Treatment Market Share by Type: 2020 VS 2026
Figure 2. HT-3951 Features
Figure 3. 2-PMPA Features
Figure 4. Meldonium Features
Figure 5. AC-253 Features
Figure 6. RO-4938581 Features
Figure 7. Others Features
Figure 8. Global Memory Impairment Treatment Market Share by Application: 2020 VS 2026
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Memory Impairment Treatment Report Years Considered
Figure 13. Global Memory Impairment Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Memory Impairment Treatment Market Share by Regions: 2020 VS 2026
Figure 15. Global Memory Impairment Treatment Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Memory Impairment Treatment Market Share by Players in 2019
Figure 18. Global Top Memory Impairment Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Memory Impairment Treatment as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Memory Impairment Treatment Revenue in 2019
Figure 20. North America Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Memory Impairment Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. F. Hoffmann-La Roche Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 29. Suven Life Sciences Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Suven Life Sciences Ltd. Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 31. Met P Pharma AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Met P Pharma AG Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 33. Dart NeuroScience LLC. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Dart NeuroScience LLC. Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 35. Omeros Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Omeros Corporation Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 37. Sunovion Pharmaceuticals Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Sunovion Pharmaceuticals Inc. Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 39. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. AbbVie Inc. Revenue Growth Rate in Memory Impairment Treatment Business (2015-2020)
Figure 41. Bottom-up and Top-down Approaches for This Report
Figure 42. Data Triangulation
Figure 43. Key Executives Interviewed


More Publications